Search Results

Nitiloop’s NovaCross Earns FDA Clearance for Treating Chronic Total Occlusion (CTO) Prior to PTCA or Stent Intervention

Nitiloop Ltd. to announce that it has received a 510(k) clearance from the U.S. Food & Drug Administration for its NovaCross™ CTO Microcatheter

April 7, 2020

·

2 min read

Deals

Microbot Medical Strengthens LIBERTY® Robotic System Portfolio with Acquisition of Novel FDA-Cleared Devices

Microbot Medical Inc. (Nasdaq: MBOT) announced today, as a continuation of its recent regulatory and future commercialization activities, together with its strategic mission to enable accessibility to multiple endovascular procedures globally, that it has acquired the assets of privately-held Nitiloop Ltd.

October 7, 2022

·

4 min read

FDA

Nitiloop Snags FDA 510(k) Clearance for its Nova Cross Extreme and Nova Cross BTK Micro Catheter

Nitiloop received FDA clearance for its new Nova Cross Extreme and Nova Cross BTK.

October 26, 2017

·

1 min read

FDA

Nitiloop Wins FDA Approval for its NovaCross Microcatheter

May 18, 2015

·

2 min read

Genetown

Microbot Medical Enhances Strategic Focus on its Endovascular Solutions

The Company is planning to focus its strategic efforts on the growing endovascular space and advancing the LIBERTY Robotic System to achieve its regulatory and commercial milestones, as well as expanding the LIBERTY ecosystem.

October 11, 2022

·

5 min read

SoniVie, A Portfolio Company Of , Announces Successful Completion Of First-In-Human Procedures Using The TIVUS Catheter

March 8, 2016

·

3 min read

Valcare Medical, An Accelmed Portfolio Company, Announces Successful First-In-Human Procedures Of The Amend Catheter Delivered Annuloplasty Ring

June 20, 2016

·

5 min read

Eximo Medical, An Accelmed Portfolio Company, Announces The Successful Completion Of A Multi-Center First-In-Human Trial In Europe With A Hybrid Catheter For Treating Complex Lesions In Peripheral Blood Vessels

April 6, 2016

·

4 min read